VAISHALI PHARMA
Back to Income Statement
|
VAISHALI PHARMA Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹99 Cr | ₹86 Cr | ₹70 Cr | ₹76 Cr | ₹54 Cr |
What is the latest Revenue of VAISHALI PHARMA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹99 Cr |
| Mar2024 | ₹86 Cr |
| Mar2023 | ₹70 Cr |
| Mar2022 | ₹76 Cr |
| Mar2021 | ₹54 Cr |
How is Revenue of VAISHALI PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹99 Cr | 14.77 | |
| Mar2024 | ₹86 Cr | 23.85 | |
| Mar2023 | ₹70 Cr | -8.12 | |
| Mar2022 | ₹76 Cr | 41.00 | |
| Mar2021 | ₹54 Cr | - | |
Compare Revenue of peers of VAISHALI PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VAISHALI PHARMA | ₹78.0 Cr | -0.2% | -23.8% | -52.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,470.0 Cr | -0.3% | 3.1% | 2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,996.0 Cr | 0.5% | -2.9% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,440.0 Cr | 0.1% | 1.4% | 37.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,417.0 Cr | 1.9% | 1.4% | 10.7% | Stock Analytics | |
| CIPLA | ₹101,445.0 Cr | -3.3% | -6.9% | -17% | Stock Analytics | |
VAISHALI PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VAISHALI PHARMA | -0.2% |
-23.8% |
-52.3% |
| SENSEX | -0% |
-10.7% |
1% |
You may also like the below Video Courses